Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia

dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:27:30Z
dc.date.available2014-05-27T11:27:30Z
dc.date.created2014-05-27T11:27:30Z
dc.date.issued2013-01-01
dc.identifierJournal of the American Geriatrics Society, v. 61, n. 1, p. 170-172, 2013.
dc.identifier0002-8614
dc.identifier1532-5415
dc.identifierhttp://hdl.handle.net/11449/74234
dc.identifier10.1111/jgs.12058
dc.identifierWOS:000313715600036
dc.identifier2-s2.0-84872253989
dc.identifier9276729087180415
dc.identifier8003931926137460
dc.identifier4043953540121335
dc.identifier0000-0002-0090-8524
dc.identifier0000-0002-1573-4678
dc.identifier0000-0001-8055-5425
dc.languageeng
dc.relationJournal of the American Geriatrics Society
dc.relation4.155
dc.relation2,174
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectdonepezil
dc.subjectlevodopa
dc.subjectmemantine
dc.subjectadult
dc.subjectaged
dc.subjectcase report
dc.subjectclinical trial (topic)
dc.subjectcognition
dc.subjectdrug safety
dc.subjectdyskinesia
dc.subjecthuman
dc.subjectletter
dc.subjectmale
dc.subjecton off phenomenon
dc.subjectParkinson disease
dc.subjecttreatment response
dc.subjectvisual hallucination
dc.subjectAged, 80 and over
dc.subjectAntiparkinson Agents
dc.subjectDementia
dc.subjectDopamine Agents
dc.subjectDyskinesia, Drug-Induced
dc.subjectHumans
dc.subjectLevodopa
dc.subjectMale
dc.subjectMemantine
dc.subjectMiddle Aged
dc.subjectParkinson Disease
dc.titleUnexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia
dc.typeOtros


Este ítem pertenece a la siguiente institución